Latest research featuring Migraine Buddy insights puts the cost of migraine to the economy in UK to £3.3 billion and in France to €3.8 billion a year
Read MoreHealint is please to join the Asia Pacific Medical Technology Association, APACMed, representing leading manufacturers and suppliers of medical equipment, devices and other key medical technology industry companies.
Read MoreHealint at American Headache Society’s 60th Annual Scientific Meeting in San Francisco, June 28, 2018
Read MoreLatest Migraine Buddy study presented at the 4th Congress of the European Academy of Neurology (EAN) in Lisbon shows migraines weigh heavily on careers, economies and budgets in Switzerland
Read MoreHealint, the developer of Migraine Buddy, the world’s largest migraine tracking and research platform, today announced data on the impact of migraine on work productivity, unveiled in a poster presentation at the Fourth Congress of the European Academy of Neurology (EAN) June 16-19, 2018.
Read MoreMigraine is a complex neurological condition. Valerie, 42, from Northeast Ohio shares what it is like to be living with it.
Read MoreLong awaited by numerous migraine sufferers, the U.S. Food and Drug Administration approves a new, preventative migraine treatment
Read MoreWorld's leading migraine researchers Prof. Peter Goadsby and Prof. David Dodick came together with Healint and over 25 patient advocacy groups in Amsterdam May 10-13, 2018.
Read MoreMeet Healint CEO Francois Cadiou at the International Patient Advocacy Summit for Migraine and Headache Disorders (MHIPAS) in Amsterdam May 10-13, 2018
Read More